These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 18473822)
21. Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns. Harbst K; Staaf J; Måsbäck A; Olsson H; Ingvar C; Vallon-Christersson J; Ringnér M; Borg A; Jönsson G Melanoma Res; 2010 Oct; 20(5):381-91. PubMed ID: 20848731 [TBL] [Abstract][Full Text] [Related]
22. Gene expression profiling and clinical outcome in melanoma: in search of novel prognostic factors. Winnepenninckx V; van den Oord JJ Expert Rev Anticancer Ther; 2007 Nov; 7(11):1611-31. PubMed ID: 18020928 [TBL] [Abstract][Full Text] [Related]
23. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Hoek K; Rimm DL; Williams KR; Zhao H; Ariyan S; Lin A; Kluger HM; Berger AJ; Cheng E; Trombetta ES; Wu T; Niinobe M; Yoshikawa K; Hannigan GE; Halaban R Cancer Res; 2004 Aug; 64(15):5270-82. PubMed ID: 15289333 [TBL] [Abstract][Full Text] [Related]
24. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements. Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744 [TBL] [Abstract][Full Text] [Related]
25. Toxicogenomics of A375 human malignant melanoma cells treated with arbutin. Cheng SL; Liu RH; Sheu JN; Chen ST; Sinchaikul S; Tsay GJ J Biomed Sci; 2007 Jan; 14(1):87-105. PubMed ID: 17103032 [TBL] [Abstract][Full Text] [Related]
26. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation]. Lázár V Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354 [TBL] [Abstract][Full Text] [Related]
27. DNA microarray and cancer. Guo QM Curr Opin Oncol; 2003 Jan; 15(1):36-43. PubMed ID: 12490759 [TBL] [Abstract][Full Text] [Related]
28. Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies. Gallagher WM; Bergin OE; Rafferty M; Kelly ZD; Nolan IM; Fox EJ; Culhane AC; McArdle L; Fraga MF; Hughes L; Currid CA; O'Mahony F; Byrne A; Murphy AA; Moss C; McDonnell S; Stallings RL; Plumb JA; Esteller M; Brown R; Dervan PA; Easty DJ Carcinogenesis; 2005 Nov; 26(11):1856-67. PubMed ID: 15958521 [TBL] [Abstract][Full Text] [Related]
29. The impact of genomics in understanding human melanoma progression and metastasis. Ren S; Liu S; Howell P; Xi Y; Enkemann SA; Ju J; Riker AI Cancer Control; 2008 Jul; 15(3):202-15. PubMed ID: 18596672 [TBL] [Abstract][Full Text] [Related]
30. Molecular classification and subtype-specific characterization of skin cutaneous melanoma by aggregating multiple genomic platform data. Lu X; Zhang Q; Wang Y; Zhang L; Zhao H; Chen C; Wang Y; Liu S; Lu T; Wang F; Yan F J Cancer Res Clin Oncol; 2018 Sep; 144(9):1635-1647. PubMed ID: 29948145 [TBL] [Abstract][Full Text] [Related]
31. Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays. de Wit NJ; Rijntjes J; Diepstra JH; van Kuppevelt TH; Weidle UH; Ruiter DJ; van Muijen GN Br J Cancer; 2005 Jun; 92(12):2249-61. PubMed ID: 15900300 [TBL] [Abstract][Full Text] [Related]
32. Comparative genomic hybridization analysis of hereditary swine cutaneous melanoma revealed loss of the swine 13q36-49 chromosomal region in the nodular melanoma subtype. Apiou F; Vincent-Naulleau S; Spatz A; Vielh P; Geffrotin C; Frelat G; Dutrillaux B; Le Chalony C Int J Cancer; 2004 Jun; 110(2):232-8. PubMed ID: 15069687 [TBL] [Abstract][Full Text] [Related]
33. cDNA array technology in melanoma: an overview. Baldi A; Santini D; De Luca A; Paggi MG J Cell Physiol; 2003 Aug; 196(2):219-23. PubMed ID: 12811814 [TBL] [Abstract][Full Text] [Related]
34. DNA microarrays: from structural genomics to functional genomics. The applications of gene chips in dermatology and dermatopathology. Sellheyer K; Belbin TJ J Am Acad Dermatol; 2004 Nov; 51(5):681-92; quiz 693-6. PubMed ID: 15523345 [TBL] [Abstract][Full Text] [Related]
35. Genomic profiling of invasive melanoma cell lines by array comparative genomic hybridization. Koroknai V; Ecsedi S; Vízkeleti L; Kiss T; Szász I; Lukács A; Papp O; Ádány R; Balázs M Melanoma Res; 2016 Apr; 26(2):100-7. PubMed ID: 26656572 [TBL] [Abstract][Full Text] [Related]
36. Apply innovative technologies to explore cancer genome. Shih IeM; Wang TL Curr Opin Oncol; 2005 Jan; 17(1):33-8. PubMed ID: 15608510 [TBL] [Abstract][Full Text] [Related]
37. Genomic profiling of malignant melanoma using tiling-resolution arrayCGH. Jönsson G; Dahl C; Staaf J; Sandberg T; Bendahl PO; Ringnér M; Guldberg P; Borg A Oncogene; 2007 Jul; 26(32):4738-48. PubMed ID: 17260012 [TBL] [Abstract][Full Text] [Related]
38. Predicting clinical outcome through molecular profiling in stage III melanoma. John T; Black MA; Toro TT; Leader D; Gedye CA; Davis ID; Guilford PJ; Cebon JS Clin Cancer Res; 2008 Aug; 14(16):5173-80. PubMed ID: 18698035 [TBL] [Abstract][Full Text] [Related]
39. Molecular diagnostics in melanoma: current status and perspectives. Dadras SS Arch Pathol Lab Med; 2011 Jul; 135(7):860-9. PubMed ID: 21732775 [TBL] [Abstract][Full Text] [Related]
40. Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling. Liu S; Ren S; Howell P; Fodstad O; Riker AI Pigment Cell Melanoma Res; 2008 Oct; 21(5):545-58. PubMed ID: 18627528 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]